BREAKING Spero Clinic Pioneers Revolutionary Treatment for CRPS, Giving Patients New Hope.BENTONVILLE, ARKANSAS, February 26, 2025 -- Chronic ...

Spero Therapeutics , Inc. (NASDAQ ... despite showing strong financial health with a current ratio of 2.68x and more cash than debt on its balance sheet. The sales were made to cover tax ...

Following these transactions, Keutzer holds 741,439 shares of Spero Therapeutics. According to InvestingPro analysis, the company maintains strong financial health with a current ratio of 2.68 and ...

The webcast may also be accessed through Spero Therapeutics’ website (www.sperotherapeutics.com) on the “Events and Presentations” page under the “Connect” tab. A replay will be ...

Spero's chief executive Ankit Mahadevia said that the company remains committed to tebipenem, despite its shift in focus to SPR720, an oral therapy for the treatment of a rare pulmonary disease ...

The Spero-QT is the next breakthrough in label-free chemical imaging and represents the second generation of high-performance infrared microscopes powered by quantum cascade laser (QCL ...

Spero’s Interim President and Chief Executive Officer, management will present and will be available for one-on-one meetings at the TD Cowen 45 th Annual Health Care Conference being held in Bos ...

The webcast may also be accessed through Spero Therapeutics’ website (www.sperotherapeutics.com) on the “Events and Presentations” page under the “Connect” tab. A replay will be ...

Spero Therapeutics, Inc. (Nasdaq: SPRO) (Spero), a multi-asset clinical-stage biopharmaceutical company, focused on ...